Mitchell Kapoor
Stock Analyst at H.C. Wainwright
(4.63)
# 910
Out of 4,698 analysts
780
Total ratings
45.4%
Success rate
12.6%
Average return
Main Sectors:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Reiterated: Buy | $45 | $24.86 | +81.01% | 37 | Sep 4, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $65 | $21.75 | +198.85% | 64 | Sep 4, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $115 | $58.13 | +97.83% | 32 | Sep 4, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $120 | $90.99 | +31.88% | 19 | Sep 3, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $115 | $110.76 | +3.83% | 61 | Sep 3, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $17.13 | - | 38 | Sep 3, 2026 | |
| SCTX Scribe Therapeutics | Reiterated: Buy | $60 | $30.81 | +94.74% | 2 | Sep 3, 2026 | |
| ALMS Alumis | Upgraded: Buy | $25 → $15 | $11.36 | +32.04% | 25 | Sep 2, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | $59 → $60 | $66.43 | -9.68% | 15 | Sep 1, 2026 | |
| INCY Incyte | Reiterated: Buy | $150 | $128.00 | +17.19% | 20 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $345 → $344 | $271.12 | +26.88% | 2 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $56.49 | +41.62% | 19 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $30 | $16.34 | +83.60% | 4 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 575.00 | kr 460.00 | +25.00% | 8 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $11.62 | +29.09% | 24 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $13.97 | +43.16% | 5 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $14.60 | +71.23% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.09 | +139.23% | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $65 | $37.61 | +72.83% | 35 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.35 | +199.40% | 21 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.05 | +242.30% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $28.00 | +60.71% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $12.68 | +97.16% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $30 | $19.00 | +57.89% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $9.12 | +174.12% | 24 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $14.32 | +214.25% | 25 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.00 | - | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $22.99 | -78.25% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.08 | +62.34% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $20.40 | - | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $3.68 | +198.91% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $4.84 | +106.61% | 16 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.66 | - | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.87 | +39.37% | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.16 | +503.45% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $5.88 | n/a | 9 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $6.44 | n/a | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.88 | n/a | 26 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0007 | n/a | 16 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.8522 | n/a | 24 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $5.93 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $3.56 | n/a | 6 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.8656 | n/a | 8 | Aug 11, 2023 |
Tyra Biosciences
Sep 4, 2026
Reiterated: Buy
Price Target: $45
Current: $24.86
Upside: +81.01%
Legend Biotech
Sep 4, 2026
Reiterated: Buy
Price Target: $65
Current: $21.75
Upside: +198.85%
Ionis Pharmaceuticals
Sep 4, 2026
Reiterated: Buy
Price Target: $115
Current: $58.13
Upside: +97.83%
Oruka Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $120
Current: $90.99
Upside: +31.88%
Halozyme Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $115
Current: $110.76
Upside: +3.83%
Summit Therapeutics
Sep 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.13
Upside: -
Scribe Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $60
Current: $30.81
Upside: +94.74%
Alumis
Sep 2, 2026
Upgraded: Buy
Price Target: $25 → $15
Current: $11.36
Upside: +32.04%
BioMarin Pharmaceutical
Sep 1, 2026
Reiterated: Hold
Price Target: $59 → $60
Current: $66.43
Upside: -9.68%
Incyte
Sep 1, 2026
Reiterated: Buy
Price Target: $150
Current: $128.00
Upside: +17.19%
Sep 1, 2026
Rated: Buy
Price Target: $345 → $344
Current: $271.12
Upside: +26.88%
Aug 31, 2026
Reiterated: Buy
Price Target: $80
Current: $56.49
Upside: +41.62%
Aug 28, 2026
Reiterated: Buy
Price Target: $25 → $30
Current: $16.34
Upside: +83.60%
Aug 24, 2026
Reiterated: Buy
Price Target: kr 575.00
Current: kr 460.00
Upside: +25.00%
Aug 21, 2026
Reiterated: Buy
Price Target: $15
Current: $11.62
Upside: +29.09%
Aug 14, 2026
Reiterated: Buy
Price Target: $20
Current: $13.97
Upside: +43.16%
Aug 14, 2026
Reiterated: Buy
Price Target: $25
Current: $14.60
Upside: +71.23%
Aug 13, 2026
Reiterated: Buy
Price Target: $5
Current: $2.09
Upside: +139.23%
Aug 12, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $37.61
Upside: +72.83%
Aug 12, 2026
Reiterated: Buy
Price Target: $25
Current: $8.35
Upside: +199.40%
Aug 11, 2026
Reiterated: Buy
Price Target: $7
Current: $2.05
Upside: +242.30%
Aug 11, 2026
Reiterated: Buy
Price Target: $45
Current: $28.00
Upside: +60.71%
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $12.68
Upside: +97.16%
Aug 7, 2026
Reiterated: Buy
Price Target: $35 → $30
Current: $19.00
Upside: +57.89%
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $9.12
Upside: +174.12%
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $14.32
Upside: +214.25%
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $12.00
Upside: -
Aug 6, 2026
Reiterated: Sell
Price Target: $5
Current: $22.99
Upside: -78.25%
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $3.08
Upside: +62.34%
Jul 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $20.40
Upside: -
May 11, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $3.68
Upside: +198.91%
Jan 13, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $4.84
Upside: +106.61%
Jan 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.66
Upside: -
Oct 24, 2025
Reiterated: Buy
Price Target: $4
Current: $2.87
Upside: +39.37%
Oct 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.16
Upside: +503.45%
Aug 19, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $5.88
Upside: n/a
Aug 11, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $6.44
Upside: n/a
Apr 30, 2025
Rated: Hold
Price Target: n/a
Current: $16.88
Upside: n/a
Apr 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.0007
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $9
Current: $0.8522
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $15
Current: $5.93
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $15
Current: $3.56
Upside: n/a
Aug 11, 2023
Reiterated: Hold
Price Target: n/a
Current: $0.8656
Upside: n/a